Form 4: CervoMed Director Boosts Stake with $59K Share Purchase
Insider Transaction Report
CervoMed Inc. Director and 10% owner Sylvie Gregoire acquired 7,847 shares of common stock across multiple transactions in mid-November 2025, totaling approximately $59,094.
Summary
- Sylvie Gregoire, a Director and 10% owner of CervoMed Inc., purchased a total of 7,847 shares of common stock in open-market transactions.
- On November 13, 2025, 4,447 shares were acquired at $7.51 per share.
- On November 14, 2025, an additional 1,707 shares were purchased at a weighted average price of $7.57, held by the Sylvie Gregoire Roth IRA.
- Also on November 14, 2025, 1,693 shares were acquired at a weighted average price of $7.55, held by the John J. Alam Roth IRA, who is the Issuer's President & CEO and Gregoire's spouse.
- The total value of these transactions amounts to approximately $59,094.
- Following these transactions, beneficial ownership, including shares held jointly with the spouse and in IRAs, increased.
Sentiment
Score: 8
Explanation: The significant insider buying by a Director, 10% owner, and the CEO's spouse indicates strong confidence in the company's future prospects and valuation. This is generally viewed very positively by the market.
Positives
- A Director and 10% owner, Sylvie Gregoire, increased her stake in CervoMed Inc. by purchasing 7,847 shares of common stock.
- The purchases, totaling approximately $59,094, demonstrate confidence from a key insider in the company's future prospects.
- The transactions include purchases made by the spouse, Dr. John Alam, who is also the President & CEO, further signaling management's belief in the company.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- The reporting person, Sylvie Gregoire, is a Director and 10% owner.
- Her spouse, Dr. John Alam, M.D., is the Issuer's President & Chief Executive Officer and a member of the Board of Directors.
- Shares are held jointly by the reporting person and her spouse, and also in their respective Roth IRAs.
Stakeholder Impact
- Shareholders: Insider buying can signal confidence to existing and potential shareholders, potentially leading to increased investor interest and a positive impact on share price.
- Management: Reinforces alignment of interests between management/board and shareholders.
Key Dates
| Date | Description |
|---|---|
| 11/13/2025 | Transaction date for the purchase of 4,447 shares of Common Stock. |
| 11/14/2025 | Transaction date for the purchase of 1,707 shares of Common Stock by Sylvie Gregoire Roth IRA. |
| 11/14/2025 | Transaction date for the purchase of 1,693 shares of Common Stock by John J. Alam Roth IRA. |
| 11/17/2025 | Filing date of the Form 4 statement. |
Recommendation
buyThe significant open-market purchases by a Director, who is also a 10% owner, and the spouse who is the CEO, signals strong insider confidence in CervoMed Inc.'s current valuation and future prospects. Such coordinated insider buying often precedes positive company developments and suggests that management believes the stock is undervalued. This action provides a strong bullish signal for investors.
Keywords
CervoMed Inc., CRVO, Insider Buying, Form 4, Sylvie Gregoire, Stock Purchase, Director, 10% Owner, John Alam, Equity Acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.